Labcorp Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Labcorp Holdings Inc in the third quarter 2026?
Labcorp Holdings Inc achieved a return on average equity (ROE) of 11.55 % in its third quarter 2026, which is below Labcorp Holdings Inc 's average return on equity, which stands at 16.49%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Laboratories industry 8 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1326, from total ROE ranking in the second quarter 2026 at 1583.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	1.74 %	1.58 %	5.07 %	7.05 %	-
Y / Y Net Income Change	0.5 %	25.51 %	30.52 %	14.83 %	54.19 %
Net Income (TTM) in Millions	1,005	1,004	943	878	856
Return On Equity (TTM)	11.55 %	11.58 %	10.92 %	10.3 %	10.22 %
LH's Total Ranking	# 1326	# 1583	# 1364	# 1480	# 1511
Equity (TTM) in Millions	8,848	8,607	8,729	8,620	8,697
Seq. Equity Change	2.8 %	-1.4 %	1.26 %	-0.89 %	2.65 %
Seq. Net Income Change	-12.14 %	7.59 %	68.59 %	-36.94 %	9.74 %

Back to LH Management Effectiveness >> LH's 5 Years Annual ROE >> Compare LH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 9
Sector	# 126
Overall	# 1326

Return On Equity Statistics
High	Average	Low
30.43 %	16.49 %	-3 %
(Jun 30 2021)		(Mar 31 2020)

LH Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2021	(Dec 31 2020) 2020
Total Equity in Millions	8,620	8,052	7,875	10,097	9,360
Y / Y Equity Change	7.05 %	2.25 %	-22 %	7.87 %	23.69 %
Net Income in Millions	878	747	419	1,281	1,557
Y / Y Net Income Change	17.48 %	78.22 %	-67.27 %	-17.75 %	88.75 %
Return On Equity	10.18 %	9.28 %	5.32 %	12.68 %	16.64 %

Back to LH Management Effectiveness >> LH's 5 Years Annual ROE >> Compare LH ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 10.18 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LH's' Return on Equity at Yahoo Finance
LH's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LH's Competitors
Subscribers only: Roe for Labcorp Holdings Inc 's Suppliers
Subscribers only: Return On Equity for LH's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Illumina Inc	31.45 %
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %
Lantheus Holdings Inc	21.72 %
Iqvia Holdings Inc	21.40 %
Denali Therapeutics Inc	21.40 %
West Pharmaceutical Services Inc	21.08 %
Brightspring Health Services Inc	20.31 %
Healthcare Services Group Inc	20.22 %
Vertex Pharmaceuticals Inc	20.08 %
Ge Healthcare Technologies Inc	20.04 %
Neurocrine Biosciences Inc	19.74 %
Ani Pharmaceuticals Inc	19.70 %
Johnson and Johnson	19.55 %
Beone Medicines Ltd	18.21 %
Pediatrix Medical Group Inc	17.28 %
Kiniksa Pharmaceuticals International Plc	17.27 %
Krystal Biotech Inc	17.02 %
Intuitive Surgical Inc	16.99 %
Ensign Group Inc	16.62 %

Date modified: 2026-10-31T09:56:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.